5-methoxytryptophan has been researched along with Inflammation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kuo, CC; Lee, CM; Liou, JY; Wu, KK; Yet, SF | 1 |
| Chen, H; Fang, L; Hong, X; Jiang, F; Kong, R; Li, Y; Qian, Z | 1 |
| Argyopoulos, CP; Bayliss, GP; Cao, G; Chen, DQ; Chen, H; Chen, L; Cheng, XH; Guo, Y; Kang, H; Li, XR; Liu, D; Ma, SX; Mao, JR; Meng, MX; Samuels, DC; Shang, YQ; Su, W; Vaziri, ND; Wang, M; Ye, F; Yu, H; Yu, XY; Zhang, L; Zhang, Y; Zhao, J; Zhao, S; Zhao, YY; Zhuang, S | 1 |
| Chang, TC; Cheng, HH; Chu, LY; Kuo, CC; Wang, KH; Wu, KK | 1 |
| Cheng, HH; Chu, LY; Kuo, CC; Wang, YF; Wu, KK | 1 |
| Hsu, YJ; Kuo, CC; Lee, GL; Wang, YF; Wu, HF; Wu, JY; Wu, KK; Yang, YS; Yet, SF | 1 |
1 review(s) available for 5-methoxytryptophan and Inflammation
| Article | Year |
|---|---|
5-methoxytryptophan: an arsenal against vascular injury and inflammation.
Topics: Animals; Anti-Inflammatory Agents; Humans; Inflammation; Mice; Tryptophan; Vascular System Injuries | 2020 |
5 other study(ies) available for 5-methoxytryptophan and Inflammation
| Article | Year |
|---|---|
Treatment with 5-methoxytryptophan attenuates microglia-induced neuroinflammation in spinal cord trauma.
Topics: Animals; Cell Line; Female; Humans; Inflammation; Mice; Mice, Inbred C57BL; Microglia; Spinal Cord Injuries; Tryptophan | 2020 |
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.
Topics: Acetylcarnitine; Animals; Canavanine; Carnitine; Case-Control Studies; Disease Models, Animal; Disease Progression; Fibrosis; Gene Knock-In Techniques; Gene Knockdown Techniques; Humans; I-kappa B Proteins; Inflammation; Kelch-Like ECH-Associated Protein 1; Kidney; Metabolomics; Mice; NF-E2-Related Factor 2; NF-kappa B; Renal Insufficiency, Chronic; Severity of Illness Index; Signal Transduction; Taurine; Tryptophan; Tryptophan Hydroxylase; Ureteral Obstruction | 2019 |
Quiescent and proliferative fibroblasts exhibit differential p300 HAT activation through control of 5-methoxytryptophan production.
Topics: Anti-Inflammatory Agents; Cell Differentiation; Cell Proliferation; Chromatography, High Pressure Liquid; Cyclooxygenase 2; Fibroblasts; Gene Silencing; Humans; Immunoenzyme Techniques; Inflammation; Mass Spectrometry; p300-CBP Transcription Factors; Promoter Regions, Genetic; RNA, Small Interfering; Sepharose; Streptavidin; Tryptophan | 2014 |
Endothelium-Derived 5-Methoxytryptophan Protects Endothelial Barrier Function by Blocking p38 MAPK Activation.
Topics: Animals; Antigens, CD; Cadherins; Capillary Permeability; Cells, Cultured; Culture Media, Conditioned; Down-Regulation; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Protective Agents; Tryptophan | 2016 |
Endothelium-Derived 5-Methoxytryptophan Is a Circulating Anti-Inflammatory Molecule That Blocks Systemic Inflammation.
Topics: Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents; Endothelium, Vascular; Endotoxemia; Female; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Mice; Mice, Inbred C57BL; Middle Aged; Tryptophan | 2016 |